Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Ayada

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|March 27, 2025
Resmetirom directly inhibits lipid accumulation in human liver-derived organoidsJiajing Li, Ibrahim Ayada, Qiuwei Pan
JAMA|December 12, 2023
Sugar-Sweetened Beverages and Risk of Liver DiseaseIbrahim Ayada, Jiajing Li, Qiuwei Pan
The Lancet. Gastroenterology & Hepatology|January 13, 2025
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitisXincheng Li, Ibrahim Ayada, Pengfei Li, et al.
Journal of Clinical and Translational Hepatology|August 12, 2024
Efficacy of Addiction Pharmacotherapy in Alcohol Use Disorder and Their Effects on Liver HealthJiahua Zhou, Jiajing Li, Qiuwei Pan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2022
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?Laurens A Van Kleef, Ibrahim Ayada, Robert J de Knegt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2022
Does NAFLD Prevalence Data Expire?Laurens A Van Kleef, Ibrahim Ayada, Robert J De Knegt
Journal of Viral Hepatitis|December 16, 2025
The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in MacrophagesJiahua Zhou, Kuan Liu, Patrick P C Boor, et al.
Hepatology International|March 7, 2024
Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinomaIbrahim Ayada, Jiajing Li, Willem Pieter Brouwer, et al.
World Journal of Gastroenterology|September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsJesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
Hepatology Communications|April 7, 2023
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US populationLaurens A van Kleef, Robert J de Knegt, Ibrahim Ayada, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|March 27, 2025
Resmetirom directly inhibits lipid accumulation in human liver-derived organoidsJiajing Li, Ibrahim Ayada, Qiuwei Pan
JAMA|December 12, 2023
Sugar-Sweetened Beverages and Risk of Liver DiseaseIbrahim Ayada, Jiajing Li, Qiuwei Pan
The Lancet. Gastroenterology & Hepatology|January 13, 2025
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitisXincheng Li, Ibrahim Ayada, Pengfei Li, et al.
Journal of Clinical and Translational Hepatology|August 12, 2024
Efficacy of Addiction Pharmacotherapy in Alcohol Use Disorder and Their Effects on Liver HealthJiahua Zhou, Jiajing Li, Qiuwei Pan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2022
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?Laurens A Van Kleef, Ibrahim Ayada, Robert J de Knegt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2022
Does NAFLD Prevalence Data Expire?Laurens A Van Kleef, Ibrahim Ayada, Robert J De Knegt
Journal of Viral Hepatitis|December 16, 2025
The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in MacrophagesJiahua Zhou, Kuan Liu, Patrick P C Boor, et al.
Hepatology International|March 7, 2024
Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinomaIbrahim Ayada, Jiajing Li, Willem Pieter Brouwer, et al.
World Journal of Gastroenterology|September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsJesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
Hepatology Communications|April 7, 2023
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US populationLaurens A van Kleef, Robert J de Knegt, Ibrahim Ayada, et al.
Pageof 3